OM
Opaleye Management’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-112,500
| Closed | -$2.24M | – | 43 |
|
|
2024
Q3 | $2.24M | Sell |
112,500
-527,500
| -82% | -$10.5M | 0.37% | 33 |
|
|
2024
Q2 | $9.91M | Sell |
640,000
-364,355
| -36% | -$5.64M | 2.27% | 11 |
|
|
2024
Q1 | $16M | Sell |
1,004,355
-252,845
| -20% | -$4.03M | 3.49% | 6 |
|
|
2023
Q4 | $21.4M | Buy |
1,257,200
+52,200
| +4% | +$890K | 5.7% | 6 |
|
|
2023
Q3 | $14.1M | Buy |
+1,205,000
| New | +$14.1M | 4.58% | 6 |
|
|
2020
Q3 | – | Sell |
-1,155,000
| Closed | -$5.34M | – | 60 |
|
|
2020
Q2 | $5.34M | Buy |
1,155,000
+105,000
| +10% | +$485K | 1.08% | 32 |
|
|
2020
Q1 | $4.04M | Buy |
+1,050,000
| New | +$4.04M | 1.07% | 29 |
|
|
2019
Q2 | – | Sell |
-1,825,000
| Closed | -$9.31M | – | 48 |
|
|
2019
Q1 | $9.31M | Buy |
+1,825,000
| New | +$9.31M | 2.58% | 14 |
|
|
2015
Q1 | – | Sell |
-975,000
| Closed | -$2.9M | – | 39 |
|
|
2014
Q4 | $2.9M | Hold |
975,000
| – | – | 1.46% | 27 |
|
|
2014
Q3 | $3.24M | Sell |
975,000
-403,584
| -29% | -$1.34M | 2.52% | 17 |
|
|
2014
Q2 | $3.49M | Hold |
1,378,584
| – | – | 3.01% | 12 |
|
|
2014
Q1 | $3.12M | Buy |
1,378,584
+24,684
| +2% | +$55.8K | 2.3% | 15 |
|
|
2013
Q4 | $2.64M | Buy |
+1,353,900
| New | +$2.64M | 2.07% | 15 |
|